microscopic polyangiitis autoimmune disease characterized systemic pauciimmune necrotizing smallvessel vasculitis without clinical pathological evidence granulomatous inflammation clinical features may include constitutional symptoms like fever arthralgia myalgia loss appetite weight loss fatigue variety organs affected causes wide range symtoms cough shortness breath hemoptysis coughing blood symtoms kidney failure skin manifestations palpable purpura livedo seizures peripheral neuropathy abdominal pain kidneys affected cases signs blood protein urine injury lead either rapidly slowly progressive kidney failure lungs affected cases findings pulmonary hemorrhage chronic pulmonary fibrosis leading respiratory mechanism disease yet fully elucidated leading hypothesis aav anca associated vasculitis develops patients genetic predisposition unknown cause triggers production panca antibodies circulate low levels environmental infection malignancy drug therapy causes upregulation neutrophils neutrophils bind pancas subsequently release inflammatory cytokines reactive oxygen species lytic enzymes cause endothelial injury resulting inflammation necrosis small damage caused kidneys specifically called necrotizing crescentic laboratory tests may reveal increased sedimentation rate elevated crp anemia kidney impairment result elevated creatinine blood detection protein red blood cells urine important diagnostic test presence perinuclear antineutrophil cytoplasmic antibodies panca myeloperoxidase constituent neutrophil granules depending organ affected special tests performed renal biopsy patients kidney failure electromyography patients peripheral neuropathy signs symptoms microscopic polyangiitis may resemble granulomatosis polyangiitis gpa another form smallvessel vasculitis typically lacks significant upper respiratory tract involvement eg sinusitis frequently seen people affected gpacitation needed immunsuppressive treatment gold standard management order achieve remission blood vessel inflammation occurs active microscopic polyangitis current immunosuppressive protocols consists combination high dose glucocorticoids combination either cyclophosphamide cases life threatening disease treatment plasmapheresis also applied immunosuppressive treatment slowly tapered period several months moment consensus total duration therapy discontinuation immunosuppression related increased risk disease flares httpsenwikipediaorgwikimicroscopicpolyarteritisnodosa